Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,110 | 18,181 | 9,334 | 12,982 | 7,278 |
| Marketable Securities | 70,689 | 76,865 | 100,672 | 110,216 | 114,885 |
| Receivables | 24,177 | 25,559 | 30,083 | 38,063 | 24,996 |
| Inventories | 43,611 | 41,279 | 35,860 | 29,245 | 29,312 |
| TOTAL | $157,602 | $171,552 | $187,397 | $198,359 | $187,142 |
| Non-Current Assets | |||||
| PPE Net | 25,168 | 24,245 | 24,517 | 22,298 | 21,536 |
| Intangibles | 21,127 | 21,365 | 21,602 | 21,840 | 22,077 |
| Other Non-Current Assets | 9,027 | 8,921 | 9,210 | 9,410 | 9,605 |
| TOTAL | $55,322 | $54,531 | $55,329 | $53,548 | $53,218 |
| Total Assets | $212,924 | $226,083 | $242,726 | $251,907 | $240,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,649 | 18,073 | 21,149 | 11,835 | 8,680 |
| Accrued Expenses | 19,043 | 25,853 | 24,878 | 28,766 | 19,284 |
| Other current liabilities | 571 | 520 | 1,022 | 4,432 | 5,190 |
| TOTAL | $38,263 | $44,446 | $47,049 | $45,033 | $33,154 |
| Non-Current Liabilities | |||||
| Long Term Debt | 53,231 | 53,157 | 53,083 | 53,008 | 52,934 |
| Other Non-Current Liabilities | 16,524 | 16,339 | 16,203 | 15,928 | 16,412 |
| TOTAL | $69,755 | $69,496 | $69,286 | $68,936 | $69,346 |
| Total Liabilities | $108,018 | $113,942 | $116,335 | $113,969 | $102,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,297 | 62,190 | 62,008 | 61,755 | 61,676 |
| Common Shares | 62 | 62 | 62 | 62 | 62 |
| Retained earnings | -189,489 | -174,129 | -152,923 | -134,247 | -127,966 |
| Other shareholders' equity | -59 | -276 | -181 | 150 | -148 |
| TOTAL | $104,906 | $112,141 | $126,391 | $137,938 | $137,860 |
| Total Liabilities And Equity | $212,924 | $226,083 | $242,726 | $251,907 | $240,360 |